Keyphrases
Omeprazole
100%
Proton Pump Inhibitors
100%
Lansoprazole
100%
Rabeprazole
100%
Pantoprazole
100%
Acid-related Diseases
100%
Zollinger-Ellison Syndrome
42%
Gastroesophageal Reflux Disease
28%
Peptic Ulcer Disease
28%
United States
14%
Pharmacokinetics
14%
Clinical Trials
14%
Comparative Safety
14%
Comparative Efficacy
14%
Long-term Safety
14%
Metabolism
14%
Safety Profile
14%
Pharmacology
14%
Critically Ill Patients
14%
Efficacy Profile
14%
Helicobacter Pylori (H. pylori)
14%
Oral Formulation
14%
English Language
14%
MEDLINE
14%
Gastric Acid Secretion
14%
Hepatic Metabolism
14%
Conjugation
14%
Upper Gastrointestinal Bleeding
14%
Acquisition Cost
14%
Drug Choice
14%
Oral Medication
14%
Hepatic Enzymes
14%
Overall Safety
14%
Proton Pump
14%
K+-ATPase
14%
Index Terms
14%
Injectable Formulation
14%
Substituted Benzimidazoles
14%
Acid Aspiration
14%
Antisecretory Agent
14%
Pharmacology, Toxicology and Pharmaceutical Science
Omeprazole
100%
Rabeprazole
100%
Proton Pump Inhibitor
100%
Lansoprazole
100%
Pantoprazole
100%
Diseases
100%
Zollinger Ellison Syndrome
42%
Gastroesophageal Reflux
28%
Peptic Ulcer
28%
Jejunum Ulcer
28%
Clinical Trial
14%
Helicobacter Pylori
14%
Side Effect
14%
Liver Enzyme
14%
Adenosine Triphosphatase (Potassium)
14%
Benzimidazole Derivative
14%
Stomach Secretion Inhibitor
14%
Acid Aspiration
14%
Proton Pump
14%
Upper Gastrointestinal Bleeding
14%
Pharmacokinetics
14%